Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Table 1 Study visits and procedures

	At inclusion	3-monthly	At PSA or symptomatic progression
Eligibility check	*
Informed consent	*
PET-CT	*		*
QOL questionnaire	*	*	*
Toxicity assessment	*	*	*
PSA measurement	*	*	*
History and physical examination	*	*	*

ISSN: 1471-2407